Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
BXP Stock Chart & Stats
Day’s Range― - ―
52-Week Range19.33p - 42.00p
Previous CloseN/A
Volume9.88K
Average Volume (3M)24.00K
Market Cap
$34.26B
Enterprise ValueN/A
Total Cash (Recent Filing)1.16B
Total Debt (Recent Filing)2.64B
Price to Earnings (P/E)4.1
Beta0.49
Next Earnings
Jan 29, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 22, 2024Dividend Yield5.55%
Share Statistics
EPS (TTM)0.09
Shares Outstanding446,112,100
10 Day Avg. Volume26,471
30 Day Avg. Volume23,995
Standard Deviation0.16
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.17
Price to Cash Flow (P/CF)2.90
P/FCF Ratio3.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Beximco Pharmaceuticals Limited Sponsored GDR RegS News
PremiumCompany Announcements
Beximco Pharmaceuticals Declares 40% Cash Dividend for 2024
PremiumCompany Announcements
Beximco Pharma Announces New Board Appointment
PremiumCompany Announcements
Beximco Pharma’s Board Restructuring Challenged in Court
PremiumCompany Announcements
Beximco Pharma Plans Virtual AGM and RebrandingPremiumCompany Announcements
Beximco Pharmaceuticals Reports Modest Growth Amid Challenges
PremiumCompany Announcements
Beximco Pharma Trading Resumes After Court Victory
PremiumCompany Announcements
Beximco Pharma Temporarily Suspends Trading Amid Legal Uncertainty---
BXP FAQ
What was Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price range in the past 12 months?
Beximco Pharmaceuticals Limited Sponsored GDR RegS lowest share price was 19.32p and its highest was 42.00p in the past 12 months.
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap is $34.26B.
When is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date is Jan 29, 2025 which is 7 days ago.
How were Beximco Pharmaceuticals Limited Sponsored GDR RegS’s earnings last quarter?
Beximco Pharmaceuticals Limited Sponsored GDR RegS released its earnings results on Jan 29, 2025. The company reported 0.027p earnings per share for the quarter, beating the consensus estimate of N/A by 0.027p.
Is Beximco Pharmaceuticals Limited Sponsored GDR RegS overvalued?
According to Wall Street analysts Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price is currently Overvalued.
Does Beximco Pharmaceuticals Limited Sponsored GDR RegS pay dividends?
Beximco Pharmaceuticals Limited Sponsored GDR RegS pays a Annually dividend of 2.078p which represents an annual dividend yield of 5.55%. See more information on Beximco Pharmaceuticals Limited Sponsored GDR RegS dividends here
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beximco Pharmaceuticals Limited Sponsored GDR RegS have?
Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding.
What happened to Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price movement after its last earnings report?
Beximco Pharmaceuticals Limited Sponsored GDR RegS reported an EPS of 0.027p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
Currently, no hedge funds are holding shares in GB:BXP
---
Beximco Pharmaceuticals Limited Sponsored GDR RegS Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.50%
12-Months-Change
Fundamentals
Return on Equity
12.86%
Trailing 12-Months
Asset Growth
-14.46%
Trailing 12-Months
Company Description
Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
---
Technical Analysis
---